---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027479"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2023-06-12T23:59:59+00:00"
generated_at: "2026-06-14T02:53:34.175300+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences announces annual meeting results; all proposals approved

## Summary
- Directors Deborah Carosella and Gregory Waller elected with 161,465 and 166,720 votes for, respectively.
- Ratification of Deloitte & Touche as auditor: 355,572 for, 11,030 against, 66,935 abstain.
- Advisory vote on executive compensation approved: 149,708 for, 25,098 against, 57,107 abstain, 201,624 broker non-votes.

## SEC filing metadata
- accession: 0000950170-23-027479
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2023-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017023027479/0000950170-23-027479-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017023027479/rkda-20230606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027479
- JSON: https://secwatch.observer/filing/0000950170-23-027479.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027479.txt

## Key facts
- Shareholder Votes
  Arcadia Biosciences, Inc. shareholders approved Election of Directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: PROPOSAL I: Election of Directors The director nominees were elected to serve as a Class II directors until the Company’s annual meeting of stockholders in 2026, or until their successors are duly elected and qualified, or their earlier resignation, death, or removal. Due to plurality election, votes could only be cast in favor of or withheld from the nominees and thus votes against were not applicable. The results of the election were as follows: DIRECTOR NOMINEE FOR WITHHELD BROKER NON-VOTES Deborah Carosella 161,465 70,448 201,624 Gregory Waller 166,720 65,193 201,624
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017023027479/0000950170-23-027479-index.htm
- Shareholder Votes
  Arcadia Biosciences, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accountants at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: PROPOSAL II: Ratification of Selection of Independent Registered Public Accountants The appointment of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2023, was ratified by the affirmative votes of the stockholders. There were no broker non-votes on this proposal. The results of the ratification were as follows: FOR AGAINST ABSTAIN 355,572 11,030 66,935
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017023027479/0000950170-23-027479-index.htm
- Shareholder Votes
  Arcadia Biosciences, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-06-06 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: PROPOSAL III: Advisory Vote on Executive Compensation The Company’s shareholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers by the votes set forth in the table below: FOR AGAINST ABSTAIN BROKER NON-VOTES 149,708 25,098 57,107 201,624
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017023027479/0000950170-23-027479-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.